Dose escalation strategies significantly impact side effect severity
GLP-1 receptor agonists are incretin-based therapies that: Enhance glucose-dependent insulin secretion Suppress glucagon release Slow gastric emptying Promote satiety and weight loss Common medications include: Semaglutide Tirzepatide Dulaglutide Liraglutide Their ability to delay gastric emptying is central to both their therapeutic benefits and perioperative risks
It should be used under professional guidance for best safety and effectiveness
A client who lost lean mass during an unstructured GLP-1 phase can rebuild a substantial portion over 3-6 months of dedicated strength training and protein-sufficient nutrition
If youre experiencing fatigue, weakness, or difficulty concentrating, B12 shots may be a helpful solution
Of the individual FROM-16 items, being worried had the highest mean score of 1.49 (max=2), followed by feeling frustrated (mean=1.37, max=2), effect on family activities (mean=1.37, max=2) and feeling sad (mean=1.35, max=2)